Full Report
Figures converted from GBP at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
Know the Business
Wise is a low-cost cross-border payments network funded by an unusually large customer-deposit float, dressed as a fintech. Personal money transfers and card spend are the volume engine; the $27.8bn in customer balances quietly carries roughly half of reported profit through interest income — which means rate cuts hit harder than the headline 16% income growth implies. The market is right that the unit economics are best-in-class, but it consistently under-prices how much of the recent profit beat was a transient rate-cycle gift, and over-prices the operating leverage from here as management deliberately reinvests every basis point of efficiency back into lower prices.
1. How This Business Actually Works
Wise runs two engines bolted to one customer relationship, and the mix matters more than the headline.
The first engine is the cross-border take. A customer sends money in one currency and receives it in another; Wise charges roughly half a percent of volume (53bps in Q4 FY2025, down from 67bps a year prior) and clears that transfer through one of eight direct connections to domestic payment systems instead of correspondent banking. About 65% of transfers settle in under twenty seconds. This engine generated $1,088m of revenue on $188bn of volume in FY2025 — the take rate is falling on purpose, and the volume is growing 23%.
The second engine is the deposit float. Customers hold $27.8bn in balances inside their Wise Account so they can spend, get paid, or sit on multi-currency cash. Wise invests this in cash, money-market funds and short bonds, and earns the prevailing rate. By design, only the first 100 bps of yield drops to Wise's "underlying" income ($195m in FY2025); everything above that is shared with customers via the Assets feature or paid out as benefits — but a meaningful chunk still lands in reported P&L as net interest after benefits paid. Total reported interest income was $769m in FY2025 against $209m of customer benefits paid, a $560m net contribution that swings with central-bank policy rates.
The cost base is the interesting part. Cost of sales (banking partner fees, payment scheme fees, card-issuance costs, credit losses) ran at 25% of revenue in FY2025; gross margin on a full-income basis is 80%. The variable cost of moving the next dollar is shrinking faster than the price Wise charges for it, which is why management can cut take rates 14bps and still expand gross margin two percentage points in the same year. Below the gross line, half of opex is people — about 6,500 employees, with roughly a third dedicated to financial-crime and compliance work that is regulatory table stakes in 70+ jurisdictions.
The business model is best understood as "Costco for cross-border money": every efficiency gain is given back to customers as lower prices, which drives volume, which drives further unit-cost improvement. That flywheel only works if scale economics keep showing up — and so far they have.
2. The Playing Field
No single peer is a clean comp; together they triangulate where Wise actually sits.
Read the chart top-right to bottom-left. Adyen sits where Wise wants to live in five years — same gross margin profile, lower growth, much higher absolute margin because it stopped reinvesting price. Wise has the better growth-and-margin combination today, but only because management is choosing to bank some of the float income; strip out interest above the 1% yield and operating margin drops closer to 20%. PayPal is the cautionary tale of what happens to a payments network when growth stalls and the moat becomes brand recognition rather than infrastructure. Western Union is the whole reason Wise exists — a 174-year-old incumbent shrinking at a 3% CAGR, trading at 1.2x EV/EBITDA because the market has stopped pretending it is anything other than a melting ice cube. Remitly is the closest pure-play in personal remittance and is barely profitable; that contrast tells you Wise's float economics, not its take rate, are doing the heavy lifting at the bottom line. dLocal is the emerging-markets specialist — narrower geographic moat, similar growth, much thinner gross margin. Payoneer is closest to the Wise Business segment alone.
What "good" looks like in this industry: 75%+ gross margin, double-digit volume growth, take rate trending down (because the alternative is margin compression from churn), and a deposit franchise that gives you optionality on rates. Wise is the only name in this set that hits all four.
3. Is This Business Cyclical?
The cross-border franchise is structurally non-cyclical; the earnings are increasingly tied to interest rates.
Volumes don't blink. People sending money home, paying overseas tuition, or running cross-border payroll do this through cycles; remittance flows held up through COVID and through the 2022-2023 inflation shock. Wise's cross-border volume grew 23% in FY2025 and 24% in H1 FY2026 against a backdrop where consumer-discretionary names were guiding down. The Business segment (24% of underlying income) is more SME-cyclical, but it is also the fastest-growing slice — volumes up 35% in H1 FY2026 — so the cyclical drag is not visible yet.
The cycle bites through the float. Wise's reported PBT is a function of central-bank policy more than most fintech investors realise. In H1 FY2026, interest income above the first 1% yield fell 11% year-over-year purely because UK and US base rates came down; this dragged reported PBT 13% lower despite underlying income growing 13% and volume growing 24%. The asymmetry is the point: a 100bp move in policy rates flows roughly $207-259m into or out of pre-tax profit on the current balance base, against a reported PBT of $731m in FY2025. Customer balances themselves are pro-cyclical — they grow with consumer wealth and SME confidence — so a rate cut combined with an SME slowdown would compound the hit.
This is the single most important thing to internalise: when management says they target a 13-16% underlying PBT margin, they are guiding to a normalised view that already strips out the rate windfall. Anyone modelling FY2024-FY2025 reported earnings as the new baseline is going to be wrong as the rate cycle continues to mean-revert through FY2026-FY2027.
4. The Metrics That Actually Matter
Active customers (M)
Cross-border volume ($B)
Customer holdings ($B)
Take rate (bps, Q4)
Underlying GP margin (%)
Instant transfers (%)
Five metrics tell you whether this business is working; everything else is noise.
Cross-border take rate is the price signal. It must trend down — 67 → 58 → 53 bps in three years is a feature, not a bug. If take rate ever stops falling without volume re-accelerating, the moat is gone, because it means scale economies are no longer feeding back to the customer. Watch the Q4 number, not the annual, since that is where the latest pricing actions show through.
Active customer growth and volume per customer together explain underlying revenue. FY2025 added 2.7m net customers and Personal volume-per-customer hit $4,143 (up 7%). The Costco analogue: customer count is membership growth; VPC is basket size. Card-only customers (~20% of personal active) have $650-$1,300 quarterly VPC and are the lower-engagement cohort; the high-volume cohort responds aggressively to price cuts.
Customer holdings ($27.8bn, +33%) is the deposit franchise. This is the hidden value driver: every $1.3bn of additional balances is worth roughly $10-13m of after-cost interest at the first-1% yield alone, before the above-1% sharing. Holdings have grown 5.7x in four years. If Wise gets the OCC US national trust bank charter it has applied for, this becomes a meaningfully bigger franchise.
Underlying gross profit margin (75%) measures whether unit economics are improving. Up two points in FY2025 against a 14bp take-rate cut tells you variable costs fell faster than price.
Instant transfer share (65%, from 49% three years ago) is the only durable product moat that is hard for incumbents to copy. Each new domestic-rail integration (PIX, Zengin, InstaPay added in FY2025-2026) ratchets this number and widens the gap with bank wires that still settle in days.
Conventional metrics like revenue growth and EPS are misleading here — the first conflates float income with operating performance, and the second is being pushed around by a 11% share-count reduction (1.42bn → 1.27bn) from buybacks and the dual-class collapse.
5. What I'd Tell a Young Analyst
Three things to anchor on, in order.
Decompose every "income" number into volume, price, and float. Wise reports an "underlying income" number and a "reported income" number, and the gap between them is interest income above the first 1% yield — a pure rate-cycle line item. Build your model from cross-border volume × take rate + card revenue + customer balances × yield, separately. If you can't tell a portfolio manager which of those four lines beat in a given quarter, you don't yet understand the business.
The market is mispricing the rate cycle in both directions. Bears focus on the H1 FY2026 PBT decline and miss that volume and customer growth accelerated. Bulls extrapolate the FY2024 reported margin and ignore that the entire above-1% interest stack will halve if base rates normalise to 2-3%. The right framing is: what is the steady-state PBT margin on underlying income at a 2.5% policy rate? Management's 13-16% target is that number, and the stock currently trades as though 18-20% is the new normal.
Watch three things and ignore most of the rest. First, the take-rate exit run-rate each quarter — if it stops falling, the flywheel is broken. Second, customer-balance growth — anything below 25% YoY would signal the deposit franchise is maturing earlier than expected. Third, Wise Platform partner wins (Morgan Stanley and Standard Chartered are the recent signals; Nubank and Itaú already shipped). Platform is the optional second act that turns Wise from a consumer fintech into infrastructure that competes with SWIFT — it is currently in "Other revenue" and not large enough to model precisely, but it is the line that would make this stock worth materially more than 30x earnings if it inflects.
The thesis-killer is not regulation, not competition, not credit losses; it is take-rate stagnation. If pricing power flips from "we choose to cut" to "we are forced to hold," the entire scale-economy-shared narrative collapses and the multiple compresses to PayPal levels. That single line in the quarterly KPI table is worth more than every other slide in the deck.
Figures converted from GBP at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.
The Numbers
Wise has crossed into "real fintech profitability" territory — FY2025 operating margin of 35% and ROE above 35% put it ahead of Adyen-class peers on returns and miles ahead of legacy remitters. But the numbers tell a more uncomfortable story underneath: roughly half of the operating-income surge from FY2023 to FY2025 came from interest income on $24B of customer balances, even as headline revenue growth slid from +73% to +16% in two years. The single metric most likely to rerate or derate the stock is the trajectory of "underlying" take-rate revenue (cross-border volume × take-rate) net of interest income — if that line keeps decelerating into single digits while rates fall, the 32× P/E does not survive contact with the model.
A. The shape of the business
Share price ($)
Market cap ($B)
Revenue FY25 ($M)
Operating margin (%)
Revenue growth FY25 (%)
Wise is a regulated cross-border payments platform that earns transaction fees on $190B+ of annual volume. The "shape" of the P&L: gross margin pushed to 79% in FY2025 (up from 62% three years ago) and operating margin sits at 35%, but a meaningful portion of both is interest income earned on customer balances now that Bank of England base rate has lifted yields on safeguarded deposits.
B. Quality scorecard — built from the financials
The provider-supplied Quality Score is unavailable for this file, so we reconstruct the quality picture directly from reported financials. Three signals matter most for a payments company at this stage of its life: return on equity, balance-sheet strength, and cash-vs-earnings consistency.
*The headline net-cash number is structurally misleading — $22.8B of the cash is customer money (multi-currency balances) sitting in the matching accounts payable line. Wise's "own" net cash position is closer to $1.4B.
The quality picture is genuinely strong on margins and returns — but the "interest-income tailwind" is doing material lifting, the 5-year revenue CAGR is decelerating fast, and a chunk of reported FCF is customer-deposit growth, not earned cash.
C. Revenue and earnings power — 11-year view
The margin curve is the entire WISE story in one image: gross margin sat in the low-60s for five years, then jumped to 77% in FY2024 and 79% in FY2025. Operating margin tripled from 11% (FY2022) to 35% (FY2025). That is not an organic operating-leverage story — Wise's underlying take-rate has actually compressed slightly as it has cut prices for customers. The margin step-change is the rate cycle plus the company starting to share customer-balance interest income with the P&L (it shares a portion with customers via Wise Interest, but keeps a meaningful share).
D. The growth deceleration
The peak-to-trough deceleration is dramatic: H2 FY2023 grew 82% YoY; H1 FY2026 grew just 9%. Some of the slowdown is the lapping of the rate-driven interest-income jump (FY2024 was the cleanest year of that benefit). But cross-border volume growth — the underlying engine — has also cooled as Wise saturates its early high-growth corridors.
E. Cash generation — and the customer-balance distortion
Read this before any cash-yield calculation. Reported operating cash flow in FY2025 ($5.8B) is roughly 11× net income. Almost all of the gap is growth in customer payables — i.e., customers depositing more money into Wise multi-currency accounts, which Wise reports as cash on its balance sheet and as a financing-like inflow inside operating activities. That is not the company's own cash generation. The chart above shows reported OCF/FCF strip out of the picture; the underlying FCF line (NI + D&A + SBC − capex) is closer to what the equity holder actually receives. Conversion ratio of underlying FCF to net income runs above 110% — clean, as you'd expect with low capex intensity, but the magnitude is much smaller than the headline number.
F. Capital allocation — buybacks and rising capex
Two real shifts since FY2023: a buyback programme that retired ~$87M of stock in FY2024 and $94M in FY2025, and a 3× jump in capex (mostly capitalised software and infrastructure for the regulated entity buildout). No dividend has ever been paid; the ~$220M proposed special dividend announced with FY2025 results is the first capital return of meaningful size and is not yet in the FY2025 cash flows. Stock-based comp at ~$76M is real dilution, but small relative to a $17.8B market cap.
G. Balance sheet — own equity is small, customer balances are large
The picture above is what a payments-institution balance sheet looks like once you separate the "two pots" — Wise's own equity has compounded from $151M (FY2018) to $1.79B (FY2025) at ~45% CAGR. The $22.8B of customer balances is matched cash-for-cash on the asset side; it is not leverage in the traditional sense, but it does mean the company carries credit, operational, and FX risk on a base ~12× larger than its own equity.
H. Returns — ROE has roughly tripled since FY2022
The ROE step-change in FY2023→FY2024 is the same story as margins — interest-income leverage on a small equity base. ROE has begun easing as the equity base inflates and interest tailwinds normalise.
I. Valuation — short history, current setup
WISE only IPO'd in July 2021, so the "20-year valuation history" anchor is unavailable. Instead, look at how the current multiple reads in three frames: the post-IPO range, the implied earnings valuation, and the peer set.
P/E (TTM, reported EPS)
P/S (FY25)
P/B (FY25)
Mkt cap / underlying FCF
Consensus target ($)
Upside to consensus (%)
At $14.00 the market is paying ~32× FY2025 EPS, ~28× underlying FCF (NI + D&A + SBC − capex), and ~10× book value. Sell-side consensus target sits near $16.46 — a high-single-digit-to-mid-teens upside, with high target near $21.13 and low near $10.30, capturing a wide range of views on whether the FY2024–25 margin level is the new normal or a rate-cycle peak.
J. Peer comparison — Wise is the unusual mix
The peer table makes the structural mismatch visible: WISE has Adyen-class margins (35% vs 47%) but PayPal-class growth (16% vs 4%, 18% Adyen growth). The 32× P/E sits between PayPal's 14× (where margins and growth are both lower) and Adyen's 47× (where both are higher). This is consistent — but it means WISE has very little room for either margins or growth to disappoint.
K. Fair value — bear / base / bull
The provider Fair Value model is unavailable for this file; we anchor instead on three independent paths and report the range.
The "bear" case is what happens if the rate cycle reverses and the market re-anchors WISE's multiple to underlying-FCF rather than reported EPS — a fair worry given that interest-on-customer-balances is doing a lot of the operating-margin work. The "bull" case requires the FY2024–25 margin level to hold and revenue growth to re-accelerate above 20% as new corridors and Wise Business mature.
The single chart that explains the price most: the half-yearly growth chart in section D. Every multiple expansion thesis requires that growth line to bend back up. Every multiple contraction risk runs through that same line bending further down.
What the numbers say
The numbers confirm that Wise has crossed the chasm into a real business: the gross-margin uplift is durable (price-led, not just rate-led), the equity base is compounding at ~45%, and underlying FCF conversion is clean. They contradict the popular "compounder at scale" framing — half of recent operating-margin expansion is interest income on customer balances, and revenue growth has decelerated from +82% (H2 FY23) to +9% (H1 FY26), a steeper drop than the consensus narrative implies. The single thing to watch into FY2026 results is the disclosure split between cross-border take-rate revenue and interest income on balances; if the former is growing in mid-teens with stable take-rate, the multiple is defensible — if it slips into single digits while rates fall, the 32× P/E rerates down before anything else fixes it.
Figures converted from GBP at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
Where We Disagree With the Market
The market is debating whether $575m of FY25 above-1%-yield interest income is a "rate-cycle gift" reversing or a "deposit franchise annuity" compounding — and both sides are arguing about the wrong thing. Customer balances are growing 33% YoY; rates are falling perhaps 100-150bps over 24 months. At those tempos, the level of interest income stays roughly flat in dollar terms through FY27 even as rate-driven yield declines, because balance compounding offsets it. That re-frames the central FY26 print debate: the question is not "will the windfall reverse" but "can balance growth keep pace with rate cuts," and the answer the data has already given (H1 FY26: balances +33%, PBT -13%) is that it is close — closer than either the 32× bull multiple or the 18× bear anchor implies. Two further disagreements compound this: the Nasdaq listing is being priced as a governance test when the US institutional baseline is structurally more permissive of founder dual-class than UK ESG screens; and Wise Platform — with five named bank/fintech contracts already live — is being valued at zero by consensus models because management has not yet disclosed it as a separate revenue line.
Variant Perception Scorecard
Variant strength (0-100)
Consensus clarity (0-100)
Evidence strength (0-100)
Months to first hard test
The 72 score reflects three narrow disagreements that are observable inside ten days (Nasdaq debut), thirty-five days (FY26 print), and six months (OCC charter, H1 FY27 print) — short enough that a PM can underwrite. Consensus clarity is mid-range because the bull/bear tape is genuinely split (sell-side averages $16.26 on $10.17-$20.85 range; one model goes to $7.06). Evidence strength is high because each variant claim ties to a specific upstream data point — balance compounding rate, founder economics, named platform contracts — rather than to a generic "market is wrong" framing.
The single highest-conviction disagreement. The bear's "$575m halves on rate normalisation" math holds customer balances static at $27.8bn. They aren't — balances grew 33% YoY in FY25 and again in H1 FY26. At 25% balance growth and a forwards-implied 3% UK base rate by end-FY27, the above-1%-yield interest line stays $450-520m, not $195-260m. The decisive variable is balance-compounding rate vs rate-cut speed, not the rate level itself.
Consensus Map
The consensus map matters because two of the seven issues are partially miscoded by the market. Issue #1 (margin reversal) embeds a static-balance assumption that is empirically false at current growth rates. Issue #3 (governance discount) is being applied with a generic template that does not survive the founder-economics specifics. Issue #5 (Platform) is being counted at zero by methodology, not by argument. Those three are where the variant edge sits.
The Disagreement Ledger
Disagreement #1 — Float compounding offsets rate compression
A consensus analyst would say the $575m of FY25 above-1%-yield interest income is a windfall that mean-reverts as policy rates normalise — and they would point to H1 FY26 PBT -13% YoY as confirmation. Our evidence reframes the same data: that decline came with cross-border volume +24% AND customer holdings +33%, which means the operating engine accelerated while the rate engine dragged. At forwards-implied UK base rate near 3% by end-FY27 (vs ~4.5% spot) and assuming balance growth decelerates to 25%, our arithmetic puts total FY27 interest income at $720-840m versus a roughly $390-450m bear case — a $260m+ PBT difference that is the entire delta between the bear's $9.07 target and a base case in the $13.24-$14.57 range. The market would have to concede that the FY24-25 reported earnings level was not a pure cycle peak; it was a cycle peak layered on top of a deposit franchise that is itself compounding fast enough to substitute. The cleanest disconfirming signal is customer-holdings growth slipping below 20% YoY at the FY26 print, or any Bank of England action that takes UK base rate below 2% materially faster than forwards imply.
Disagreement #2 — Nasdaq inverts the governance discount
A consensus analyst would say the dual-class extension to 2035 is a governance overhang and cite Hinrikus, ISS / Glass Lewis, and PIRC as evidence. Our evidence reframes the marginal-seller question: it is the UK pre-listing screen — the FTSE 4Good / UK governance code apparatus — that has been pricing the discount, not US growth-fund mandates that have lived comfortably with Meta, Snowflake, Palantir, and the Roblox cohort at premium multiples to non-dual-class peers. Käärmann's $4.6bn economic stake against $269k cash compensation is the structural negative of the textbook principal-agent problem; the FinanceFeeds note explicitly observes "US markets have historically been more accommodating of such structures." The market would have to concede that the discount narrows on listing day rather than widens, which is the exact opposite of the Seeking Alpha framing. The cleanest disconfirming signal is Nasdaq ADV failing to widen above $33m within thirty sessions, OR a US ESG fund publicly screening out (Calvert, Domini) — neither has happened pre-listing.
Disagreement #3 — Wise Platform is a free option in consensus
A consensus analyst would say Wise Platform is "the supposed second leg" with no quantifiable revenue. Our evidence reframes the methodology: the value is unbooked because management has not disclosed it, not because it does not exist. Standard Chartered, Morgan Stanley, Nubank, Itaú, Wealthsimple and Raiffeisen are all live or contracted — five named institutional partners against an addressable legacy-bank revenue pool the AInvest piece sizes at $225bn. dLocal, the closest B2B FX-rails comparable, trades at 7.3x EV/Sales for a thinner-margin business. Even modest contribution (5% of FY27 group income at a B2B multiple) adds $1.3-2.6bn of equity value; a 10% contribution and a 9x multiple gets to $4bn — 23% of the current market cap. The market would have to concede that the optionality is real and capitalisable on disclosure rather than aspirational. The cleanest disconfirming signal is FY26 segment reporting (4 Jun 2026) leaving Platform inside "Other revenue," or any of the five named partners reducing scope publicly.
Evidence That Changes the Odds
The strongest piece of evidence is row 2: H1 FY26 prints volume +24% and holdings +33% against PBT -13%, in real time, against a rate-cut backdrop. That single data triplet contains both the bear signal (the rate engine dragging) and the variant signal (the operating and float engines absorbing roughly half the hit). The FY26 full-year print is the next clean read, and rows 3-4 frame the listing-day governance test that runs in parallel.
How This Gets Resolved
The resolution path is unusually concentrated: rows 1, 2, 3, 6, and 7 all land between 8 May and end-June 2026 — a fifty-day window that contains the listing, the FY26 print, the index reviews, and the AGM. By 1 July 2026 a PM should have most of the data needed to keep, retire, or invert all three variant views. Rows 4, 5, and 8 stretch through H2 2026 into early 2027 and are the slower-to-resolve overhangs.
What Would Make Us Wrong
The bear's static-balance assumption is wrong on the math, but it is not wrong on the direction. If UK base rate cuts faster than forwards imply — say the BoE goes to 2.0% by mid-2027 to combat a domestic recession — and SME confidence weakens enough to slow customer-holdings growth from 33% to 15%, our "balance compounding offsets" arithmetic compresses to a point where the above-1%-yield line drops to roughly $325m by FY27, not the $450-520m we anchor on. That scenario does not require either the bull or the bear thesis to be correct on the franchise; it just requires a UK macro pull-down to compound with the rate move. The cleanest single tell is customer-holdings growth slipping below 20% YoY at the FY26 print — at which point our first variant view should be retired immediately rather than litigated.
The Nasdaq governance-discount inversion is the most fragile of the three. The Meta / Snowflake comp set is real, but Wise has a specific feature those names do not — three live regulator settlements, a CEO with two personal regulator fines, and an interim CCO. A US ESG fund or activist could correctly argue that those facts justify a discount irrespective of the founder economics, and the marginal-seller flip we expect on listing day might not materialise. If first-30-day Nasdaq ADV stays below $26m and a major US payments analyst initiates with an Adyen-discount framing rather than an Adyen-comp framing, the listing was a technical event, not a re-rating event, and our second view should be retired alongside the bull's $19.86 target.
The Wise Platform optionality view depends on management actually disclosing the line. They have not in two years, and there is no contractual reason they must. If FY26 reporting and H1 FY27 reporting both leave Platform inside "Other," the value continues to sit on Wise's balance sheet without ever being capitalised in the equity — and a perfectly correct DCF that gives Platform a small explicit value does not have to mean the market is wrong; it means the market is rationally refusing to underwrite an undisclosed line. The cleanest tell is the segment table on 4 June 2026: if Platform is not separately broken out, mark it back to optional and demand a disclosure event before re-engaging.
The single thing that connects all three risks: a falling-rate, slowing-volume, opaque-Platform print at FY26 results would simultaneously falsify the float-compounding view, the listing-narrows-discount view, and the Platform-option view. That is the asymmetric scenario worth pre-mortem-ing.
The first thing to watch is the customer-holdings line at the FY26 print on 4 June 2026 — if it lands above $37bn, the central variant disagreement is intact; below $33bn, retire it.
Figures converted from GBP at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
Bull and Bear
Verdict: Watchlist — wait for FY26 results to print. Both advocates are arguing about the same building: Bull says it is a deposit franchise dressed as a fintech; Bear says it is a payments fintech that briefly looked like a bank because of a 5.25% UK base rate. The decisive evidence — whether Underlying PBT margin holds inside the 13-16% guidance band as policy rates normalise — is observable at the FY26 print in May-June 2026 and is already partially printing in H1 FY26 (PBT down 13% with volume up 24%). Until that print lands, paying 32× FY25 reported EPS for a business whose FY25 reported margin is partly a rate-cycle gift carries clear asymmetric downside relative to a clean re-entry post-print. The franchise is real (74% instant transfers, $28bn float compounding 33% YoY, $4.6bn founder stake), so this is not "Avoid" — it is "wait for the data point that resolves the debate before underwriting the multiple."
Bull Case
Bull's price target: $19.85 over 12-18 months. Method: 40× FY26E underlying EPS of ~$0.49, equivalent to a 15% discount to Adyen's 47× multiple, justified by Wise's faster volume growth (24% vs 18%) and an embedded float annuity Adyen lacks. Primary catalyst is the US primary listing in Q2 2026 (June-August window), which adds index inclusion, eligible US institutional bid, and a sell-side coverage step-change for a name currently capacity-constrained at $21m/day ADV. Disconfirming signal: Q4 FY26 cross-border take-rate prints flat or higher quarter-over-quarter without volume re-accelerating above 25% YoY — that data point would say the scale-economies-shared flywheel has stalled.
Bear Case
Bear's downside target: $9.07 (market cap ~$11.5bn vs current ~$17.5bn — a 34% drawdown) over 12-18 months. Method: multiple compression of underlying FCF (FY25 $608m) to 18× as the market re-anchors away from reported EPS toward management's own steady-state framework — between PayPal (~14×) and Adyen (~26×). Primary trigger is the FY26 full-year print in June 2026, the first full year in which (a) Mission Zero pricing compresses both halves of margin by design, (b) the 1%-yield framework is fully tested under falling rates, (c) $46m of dual-listing costs land, and (d) consensus $16.26 target meets an Underlying PBT margin print at or below the 13% floor. Cover signal: cross-border take-rate stops falling for two consecutive quarters AND volume growth re-accelerates above 30% — together they would prove the unit-economics flywheel is structural rather than cyclical. A separately disclosed Wise Platform revenue line crossing 10% of total income with named contract economics would also do it.
The Real Debate
Verdict
Watchlist. The Bear carries more weight today because the central tension — annuity versus windfall on the $575m above-1% interest line — is already partially resolving against the Bull in real time: H1 FY26 printed PBT down 13% with cross-border volume up 24%, which is what a rate-cycle gift unwinding looks like, not what a compounding deposit franchise looks like. The single most important tension is therefore #1, annuity versus windfall, and the FY26 print in May-June 2026 will be the data point that either re-rates the multiple or compresses it toward the bear's 18× underlying FCF anchor. The Bull could still be right because the underlying franchise — 74% instant transfers, seven direct rails, a 5.7×-in-four-years deposit base, and $4.6bn of founder skin in the game — is genuinely non-cyclical, and if Underlying PBT margin holds inside the 13-16% band even as rates fall, the 32× multiple is defensible. The verdict changes to Lean Long if the FY26 print delivers Underlying PBT margin at the upper half of the band, take-rate stops falling, and at least one regulator settlement closes cleanly; it changes to Avoid if FY26 PBT margin breaches the 13% floor or any of the three live consent orders escalates. Until that print, paying 32× reported FY25 EPS for a business whose reported FY25 earnings power was partly a rate windfall is a setup with poor entry asymmetry against a known catalyst date.
Watchlist — The franchise is real, the rate-cycle exposure is real, and the FY26 full-year print in May-June 2026 is the observable data point that resolves which one is the steady state. Wait for the print.
Figures converted from GBP at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
Catalysts — What Can Move the Stock
The next six months hinge on a single hard-dated event: Wise begins trading on Nasdaq on Monday 11 May 2026, ten days from today, with the LSE moving to a secondary listing and the FY26 results landing in USD under US GAAP in early June. Everything else — the $46m of one-off costs landing in the FY26 print, the OCC trust-bank decision, the multi-state AML monitor reports, the $33m share-repurchase programme that is roughly half complete — sits behind that single ten-day window. The calendar after the listing is busy but lower-impact until November's H1 FY27 print is the first clean test of whether the deliberate margin compression actually produces the volume response management has promised.
Hard-dated catalysts (next 6m)
High-impact catalysts
Days to next hard date
Signal quality (1-5)
The dominant catalyst is the Nasdaq debut on 11 May 2026. Court approval landed 27 April; the Scheme of Arrangement becomes effective 8 May; the existing Wise plc shares delist and Wise Group plc shares begin trading on Nasdaq the following Monday. The first three weeks of US tape — flow, sponsorship, sell-side coverage step-up — set the multiple framework against which every subsequent catalyst is read. ADV today is $21m on a $13.8bn float; if the US listing fails to widen the daily turnover to anything resembling a US-comp, the bull's "index inclusion + institutional bid" thesis collapses on day one.
1. Ranked Catalyst Timeline
The ranking puts the Nasdaq debut, the June FY26 print, and the AML monitor first because they share the same underlying dynamic — they each test whether the FY24-FY25 reported margin level is the new baseline or a rate-cycle peak. The OCC charter is the only purely-future-positive catalyst on the page; everything else is a beat-or-miss against expectations the company has already set.
2. Impact Matrix
Three of these six items resolve the central debate identified in the bull/bear work: whether the FY24-25 margin step-change was rate-cycle pull-forward (bear) or a structural re-rating to deposit-franchise economics (bull). The Nasdaq listing is multiple-driven; the FY26 print and the H1 FY27 print are earnings-driven; the OCC charter is structural; the monitor and Platform inflection are tail risks/optionality.
3. Next 90 Days
The 90-day window is unusually concentrated for this name — three of the four highest-ranked catalysts cluster between 8 May and early June.
The 90-day window is unusually rich for an LSE-primary fintech: the listing, the first US-GAAP earnings, an index review, an AGM and a quarterly trading update all land within ten weeks. The order of release matters — if the listing flow is weak, the FY26 print has to do all the work to defend the multiple, and a missed UPBT band would compound rather than offset.
4. What Would Change the View
Three observable signals over the next six months would force the bull-versus-bear debate to resolve. First, whether Nasdaq ADV materially widens above the $21m LSE baseline within 30 sessions — this is the cleanest empirical test of the listing-rerating thesis, and a failure here removes the largest single bull catalyst of the year. Second, the FY26 UPBT margin print stripped of the $46m one-off costs: if the underlying margin lands inside 13-16% it ratifies the management framework and supports the variant thesis that the rate-cycle reversal is already priced; if it slips below the floor the bear's "rate windfall mispricing" thesis becomes the consensus read. Third, whether the Q1 FY27 take rate stabilises in the 50-52bps band rather than continuing to compress: a flat take rate with volume above 20% would confirm the scale-economies-shared flywheel; continued compression with volume below 20% would prove what management is calling Mission Zero is in fact pricing-pressure-as-a-feature. Together these three signals — listing flow, underlying margin under the new regime, and take-rate stabilisation — are the event path that would force a portfolio manager to update.
The Full Story
Figures converted from GBP at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.
In four years as a public company Wise's narrative has bent twice. The mission ("money without borders") has not changed; the financial story has been rewritten three times — first to show off interest income, then to bury it under a new "underlying" framework, and now to explain a deliberate margin compression that funds a doubled spend plan and a US listing. Through every reframing, the customer-volume engine has done what management said it would; the lead profitability metric, however, has been moved often enough that comparing today's promise to yesterday's is an exercise in translation. Credibility on growth is high; credibility on KPI consistency is the weak spot.
1. The Narrative Arc
Three narrative phases. FY22–H1 FY23: "growth, scale, mission" with EBITDA margin pegged at 20%+. FY23–FY24: the interest-rate windfall — Wise creates a new "Income" line, then a year later a new "Underlying" line to ring-fence interest above the first 1% yield. FY25–FY26: "trillions not billions" — a US dual-listing announcement, accelerated price cuts, and a $2.6bn two-year reinvestment plan that compresses margin by design.
The growth engine has been remarkably linear; the story attached to it has not. Pre-IPO and through Q4 FY22, management spoke as a mission-driven scale-up with a single P&L line (revenue) and a single profitability target ("≥20% Adjusted EBITDA margin"). The instant-rate-rise of 2022–23 forced an overhaul: the company began earning meaningful net interest on $9–26bn of customer balances, and the original P&L could no longer be read without misleading the reader either way. The fix arrived in two waves — "Income" added net interest in H1 FY23, then "Underlying" stripped out the bit above 1% in FY24 — and the lead profit metric quietly migrated from Adjusted EBITDA to Underlying PBT. By FY25 the headline target margin range had nominally fallen from "≥20%" to "13–16%", even though the underlying business is more profitable.
2. What Management Emphasized — and Then Stopped Emphasizing
3. Risk Evolution
The most telling change is the FY25 consolidation from ten-plus equally-weighted "principal risks" down to five top-tier risks: financial crime/fraud, cyber/data privacy, operational resilience, liquidity, and regulatory. Operational resilience was a process discipline in FY22; today it sits on the principal risk page with explicit five-year horizon language about DORA, UK OpRes, and Australian CPS230 all hitting the same global infrastructure. The new prominence of liquidity risk is unusual for a payments firm and reflects the simple math of sitting on $26bn+ of customer balances — Wise now talks openly about social-media-driven "run on the bank" scenarios as a stress test.
The interest-rate-risk line, conversely, only emerged in FY23/FY24 once bonds and money-market funds became material to net interest income; AI moved from an unmentioned topic in FY22 to an "elevated emerging risk" appearing on multiple risk lines (financial crime, cyber, model governance) by FY25.
4. How They Handled Bad News
5. Guidance Track Record
Management credibility score
Active customers (FY25, m)
Credibility score: 7.5 / 10. Wise has consistently met or exceeded the volume- and growth-side promises that mattered to a buyer of the equity story; the H1 FY23 / FY23 growth beats were emphatic, and the operational milestones (instant %, direct connections, account adoption) have all printed. The slight ding is the frequent reframing of the lead profitability metric — Adjusted EBITDA → Income → Underlying Income → Underlying PBT in three years — and the resulting discontinuity that makes the "13–16% margin" bar look lower than the "≥20% Adj EBITDA" bar it replaced. The reframing was economically defensible (the interest windfall was exogenous) but was not paired with a clear bridge that mapped the old target to the new one. On governance: handling of the CEO's HMRC/FCA matter, the Briers transition, regulator settlements, and the onboarding pause has been transparent and procedural rather than spun; the only opaque episode is the un-engaged-with public opposition from co-founder Hinrikus to the US-listing voting structure.
6. What the Story Is Now
The company today is being described as a "network for the world's money" with a long runway: $43 trillion TAM, ~5% personal share, ~1% SMB share, with infrastructure (direct connections to seven domestic payment systems, soon eight; 70+ licences; 74% instant transfers in Q2 FY26) that Wise believes is now the moat. The financial story is a deliberate margin compression — UPBT 22% in H1 FY25, dropping to 16% in H1 FY26 — caused by price cuts (take rate 67bps → 52bps), tripled marketing, and dual-listing project costs, and explicitly sized as a $2.6bn two-year reinvestment plan. The US dual-listing (planned Q2 2026, after a contested vote) is positioned as the financing-and-awareness step that unlocks the next phase.
What's been de-risked: the cross-border take-rate moat (52bps still beats banks 3–4x over); customer growth (consistent 18–25% across four years through rate cycles, FX volatility and an onboarding pause); customer balances and the optionality they create (Assets product crossing $6.7bn in H1 FY26); and infrastructure dependency on partners (direct connections reducing partner-bank reliance).
What's still stretched: the leap from "$188bn in FY25" to "trillions" of volume requires a step-change in Wise Platform B2B revenue (currently ~5% of volume; targeted at >10% medium-term, >50% long-term), and there is no evidence of run-rate yet — Standard Chartered, Morgan Stanley, Nubank and Itaú signed but contributing modestly. The dual-class governance changes for the US listing concentrate voting power in the CEO at the moment a co-founder publicly objected — a small-but-real governance discount the equity may now carry. Margin compression assumes the volume response to lower prices materialises; H1 FY26 already shows the pattern with 24% volume vs 6% revenue growth, but this is fragile if rate cuts happen faster than scale efficiencies.
What the reader should believe: the customer / volume / instant-payment / account-adoption story (every metric has compounded for four years). What the reader should discount: the headline change in the profitability target from "≥20% EBITDA" to "13–16% UPBT" — economically the same envelope, optically a downgrade that makes peers' P&Ls hard to compare. What the reader should watch: whether Wise Platform crosses double-digit % of volume by FY27, whether the post-listing US institutional bid materialises, and whether the next CFPB/MMET-style enforcement remains modest as Wise scales into a larger US footprint.
Financial Shenanigans — Wise plc (WISE)
Figures converted from GBP at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.
1. The Forensic Verdict
Risk grade: Elevated (45/100). Wise's reported numbers reconcile, the auditor (PwC) has not flagged a control issue, receivables actually shrank in FY2025 while revenue grew, and the headline IFRS gross-up of customer balances on cash-flow and balance-sheet lines is a structural feature of any e-money payment institution rather than aggressive accounting. What pushes the grade above "Watch" is a different problem: a CEO with a 49.3% voting bloc who was personally fined by both HMRC and the FCA, a dual-class structure that was just extended ten years to 2036 in a vote that ISS and Glass Lewis say they were briefly misled about, three control-environment leadership changes (CFO, Chief Compliance Officer, Head of Internal Audit) inside a twelve-month window, and three live regulator settlements in the US, UK and ADGM — all wrapped around a "Underlying PBT" framework, introduced for FY2024 reporting, that excludes the most volatile component of earnings (interest income above the first 1% yield). The single data point most likely to change the grade is the PwC audit opinion language for FY2026, the first year the new compliance and finance leadership team owns the books and the first year of the dual-listing transition.
Forensic Risk Score (0-100)
Red Flags
Yellow Flags
FY25 CFO / Net Income
FY25 Underlying FCF / Underlying PBT (%)
The CFO/NI ratio of 10.8x is mechanical: cash held on behalf of customers ($22.1bn) sits inside trade payables and is matched by safeguarded cash and short-term investments, so growth in customer balances flows through CFO. The economically-meaningful cash measure is management's own "Underlying free cash flow" of $431m in FY2025, which sits at 118% of underlying PBT — clean, not stretched. Investors who cite the headline $5.82bn CFO are quoting a number that is not theirs.
Top two concerns. (1) Governance concentration combined with regulator history: a CEO with 49.3% voting power, an FCA fine on the CEO personally for failure to disclose a $503k HMRC tax penalty, three near-simultaneous control-officer departures, and live consent orders from CFPB and the US Multi-State MSB Examination Taskforce. (2) The "Underlying PBT" lead metric, adopted in FY2024 reporting, mechanically smooths reported margin against the rate cycle by capping the interest-income contribution at a 1% yield — a definitional choice that is internally consistent and disclosed, but unambiguously a presentation aid.
Shenanigans scorecard
Three categories drive the elevated score: metric architecture (#12), customer-balance presentation (#13) and the related cash-flow gross-up (#8). The earnings-quality column is mostly clean — the company is not playing games with revenue recognition, accruals, capitalisation or impairments.
2. Breeding Ground
The structural setup tilts toward management discretion, not external challenge. Käärmann's economic stake of roughly 18% converts to 49.3% voting via Class B 9-vote shares; Notorious OÜ (his investment vehicle) holds another 13.1% of voting rights. The dual-class sunset has just been extended from July 2026 to 2036 inside a bundled vote on the move of the primary listing to the US, a bundling that ISS and Glass Lewis publicly admitted they "initially failed to identify" and that co-founder Taavet Hinrikus opposed. Käärmann's voting power is contractually capped at one vote below 50% while CEO and one vote below 35% if he steps down — meaningful only because without the cap he would otherwise control more than 50%.
The redeeming factor is that Käärmann himself takes no variable pay — he draws a $255k salary and has no bonus, no LTIP, no PSP. That removes the most common compensation lever for accounting aggression. The next most senior executives, including new CFO Thomassin, do have LTIPs at 400% of salary, weighted 40% TSR / 20% cross-currency volume / 20% Underlying PBT margin / 20% NPS. Volume growth as an incentive line is a flag worth monitoring because it can be hit by reducing take-rate — already a stated strategy in the FY26 transcripts ("Mission Zero" pricing) — without earnings discipline. The Underlying PBT margin component has a 10% threshold floor against a 13-16% guidance range, which gives the Remuneration Committee meaningful discretion to vest below the publicly-communicated band.
PwC has been auditor since the 2016 SE-domicile period; senior partner Mark Jordan rotates after FY2026 and there is no audit tender planned for FY26 — investors should treat the FY26 audit opinion (the partner's last) as the cleanest backward-looking signal available before the move to US GAAP and a new audit relationship.
3. Earnings Quality
Reported earnings look earned, with one architectural caveat. Revenue, gross profit, operating profit and net income tie out cleanly across years, the gross margin trend (FY2022 66% → FY2025 79%) is consistent with management's stated take-rate reduction being more than offset by mix shift to high-margin Card and Other revenue lines, and there is no contract-asset, capitalised-cost or other-asset balance that has decoupled from revenue. The architectural caveat is that the largest contribution to reported pretax income is now interest income on customer balances ($769m FY25, +71% YoY despite falling rates) — booked separately on the income statement, but pushed below the "Underlying PBT" measure management directs investors toward.
The FY2024 single-year mismatch — receivables grew 77% while revenue grew 47% — is worth noting but is not a revenue-recognition red flag. Wise's "receivables" line is dominated by amounts due from card schemes and partner banks in transit, which scale with card spend; FY2024 was the first year of material scale for the Wise card business. The FY2025 reversal — receivables down 22% on revenue up 17% — is the test that matters and it passed cleanly.
The FY2024 step-change in operating margin (16.3% → 35.5%) is the single most important earnings event in this dataset and deserves attention. It is not a revenue-recognition or capitalisation event — it is the first full year in which interest income on customer balances ran at materially elevated rates (the Bank of England base rate stayed at 5.25% for most of the year), and management chose to retain the entire excess yield as profit rather than pass it through to customers. Whether that margin is sustainable is the central business question; whether it was earned is not in dispute.
The framework caps the interest-income contribution to "Underlying income" at the first 1% yield. In FY2025 that meant $575m of interest income was excluded from the lead earnings metric, alongside $209m of customer rebates that fund the high-yield customer accounts ("Wise Interest" / "Wise Assets" benefits). The reconciliation is fully disclosed and consistent across FY24 and FY25, but it does mechanically smooth the underlying margin against the rate cycle — a feature management will lean on as rates fall in FY26 and again has the practical effect of preserving the 13–16% Underlying PBT margin guidance band even as reported PBT margin moves with the rate environment.
Capitalisation, reserves and impairment behavior are clean. Capex was $44.7m in FY2025 (2.1% of revenue), up from $13.4m the prior year because of the Brussels HQ build-out and infrastructure investment — not customer-acquisition or capitalised-software inflation. Intangibles on the balance sheet are $5.2m (down from $8.2m), so there is no goodwill-amortisation or intangibles-build to manage. There were no restructuring charges, no impairment events, no big-bath behavior around the CFO transition, and no inventory or accrual line worth flagging.
4. Cash Flow Quality
The headline cash flow statement is uninformative without the customer-balance overlay. Reported operating cash flow of $5.82bn in FY2025 — 10.8x net income — is overwhelmingly the IFRS-mandated gross-up of customer balance growth flowing through working-capital lines. This is not a forensic distortion in the traditional sense (it is the only correct presentation for a regulated e-money institution), but it makes the headline CFO/NI and FCF/NI ratios the wrong tool for assessing this business. Management's disclosed Underlying Free Cash Flow of $431m (FY2025) is the right benchmark and is converting at 118% of Underlying PBT — fundamentally clean.
The right way to read the chart above is that the $5bn-plus gap between net income and CFO each year is almost entirely the change in customer balances (trade payables grew from $17.6bn to $22.8bn in FY25 alone, a $4.8bn move). Wise's economically-controllable cash conversion is a different — and reasonable — story.
The $18bn-plus delta between reported "free cash flow" and the underlying measure is a real disclosure risk if a downstream investor or screener pulls the headline number from the cash-flow statement and treats it as cash generation. It is not an accounting choice Wise can change — IFRS dictates it — but it is a metric that needs the management bridge to be useful.
There are no working-capital lifelines, factoring, supplier finance or receivable sales disclosed. There is, however, one financial-engineering layer worth flagging: in FY2025 Wise put in place a $673m "Safeguarding Insurance" policy that allows the company to use a portion of safeguarded customer funds for operational liquidity (sized to FCA-permitted limits). This is a regulatory innovation, not an accounting one — but it does change the practical liquidity dynamics, and is the new mechanism that should be monitored alongside the $194m revolving credit facility (now unsecured following the November 2024 BBB ratings from S&P and Fitch).
5. Metric Hygiene
This is the single biggest forensic concern in the file. Wise's metric architecture changed in FY2024 — the lead earnings metric switched from "Adjusted EBITDA" (with a stated target of "20% or higher" margin) to "Underlying PBT" (with a stated guidance of 13-16% margin). The Underlying PBT framework excludes the most volatile component of earnings — interest income above the first 1% yield — by construction. The framework is internally consistent, fully reconciled and stable across FY24 and FY25, but it is unambiguously a presentation choice that softens the headline-margin versus target comparison and smooths reported earnings against the interest-rate cycle. It is also the metric that drives executive compensation.
The change of lead metric from Adjusted EBITDA to Underlying PBT was justified at the FY24 results call as "the metric that best reflects how we run the business." That is a defensible position — Underlying PBT does include depreciation and stock-based compensation, which makes it stricter than the prior EBITDA frame in those respects. But the simultaneous decision to cap interest-income recognition at the first 1% yield is the part that directly affects comparability: every basis point of base rate above that floor is excluded from the management metric and parked in the reconciliation. A 1.0% policy rate environment would put 100% of interest income in the underlying metric; a 5.0% rate environment puts roughly 25% of it in the underlying metric. The metric is therefore most generous, relative to the alternative of including all interest income, exactly when interest income is highest — which is the period now ending.
Three top-line numbers, all roughly $2.0-2.7bn, all internally consistent, all used in different parts of the FY2025 reporting package. Investors who anchor on "Income" risk overstating the size of the operating business by 36% relative to IFRS revenue; investors who anchor on Underlying income risk understating the contribution of the rate environment to FY24-FY25 reported earnings.
6. What to Underwrite Next
The accounting risk does not appear large enough to be a thesis breaker, but it is large enough to require a margin of safety — somewhere between a position-sizing limiter and a small valuation haircut on the rate-driven component of earnings. The fundamental shenanigan signature is absent: revenue is earned, receivables are clean, capex and intangibles are tiny, no factoring, no acquisitions to mask, no big-bath behavior, auditor is mid-tenure with no qualification language. The risk that does remain is concentrated in three areas: governance (one shareholder controls the vote, and that shareholder has been personally fined by two regulators), metric definition (an Underlying PBT framework that systematically excludes the cyclical component of earnings exactly when it is highest), and compliance (three live regulator settlements with one independent monitor in place, in a business whose fundamental input is regulated cross-border money movement).
Track these five things in the next two reporting cycles:
- PwC FY2026 audit opinion language. Partner Jordan rotates after FY26 and the company is preparing to switch to US GAAP for the dual-listing. Any emphasis-of-matter, key-audit-matter elaboration, or change to the customer-balance critical-judgement disclosure is the highest-signal observation available before the new auditor starts.
- The $45m dual-listing transition costs. If these are formally moved into a "non-underlying" reconciling item in FY26 reporting — separate from the regular Underlying PBT framework — the metric architecture has loosened. If they are absorbed inside underlying PBT, the discipline holds.
- MMET independent monitor reporting. The July 2025 consent order with the US Multi-State MSB Examination Taskforce includes a multi-year independent monitor; any extension, escalation or finding from that monitor is the most concrete near-term compliance read.
- Underlying PBT margin in a falling-rate environment. H1 FY2026 already showed the framework holding (16.3% margin vs 22% prior period) but excluding the $45m one-offs. The FY26 full-year print is the first full-cycle test of whether the 1%-yield framework actually delivers the 13-16% guidance band when rates fall, or whether the framework produces a margin print well below the band that requires a further definitional adjustment.
- Replacement of Chief Compliance Officer. Steyn resigned 31 December 2024 with an interim in place. A permanent CCO appointment with a clear remediation mandate is the cleanest signal that the FY25 risk-factor language ("strategically strengthen our sanctions and AML/TF controls, remediate all known control gaps") is being executed.
Three signals would upgrade the grade toward Watch (sub-30): a clean PwC FY26 opinion, MMET monitor exit, and a permanent CCO appointment. Three signals would downgrade it toward High (above 60): a restatement of Underlying PBT or the income-framework definition, a regulator finding that broadens beyond AML into product economics, or any indication that the $45m dual-listing costs become a recurring "non-underlying" line. The forensic finding here is not that the numbers are wrong — they are not — but that the architecture around the numbers has moved in the company's favor at the same time as the governance structure has been entrenched for another decade. That combination warrants underwriting, not abstention.
Bottom line for position-sizing. The accounting risk does not justify avoiding the position; it justifies sizing for the realistic distribution of regulatory outcomes (medium probability of further AML-related fines in the $13-65m range over the next 24 months) and discounting the rate-driven component of earnings (≈$575m in FY25) at a higher rate than the underlying business. For an investor underwriting Wise on its long-run cross-border take-rate compression and operational leverage, this work is a footnote. For an investor relying on the $5.8bn cash flow statement headline or the 35% reported PBT margin as a steady-state assumption, this work is a thesis breaker.
The People
Figures converted from GBP at historical FX rates — see data/company.json.fx_rates. Ratios, margins, multiples, share counts, and percentages are unitless and unchanged.
Governance grade: B. A founder-CEO with a $4.5bn personal stake who refuses bonus or LTIP is the closest thing to natural shareholder alignment money can buy — but that same founder just bundled a 10-year extension of his super-voting rights with the US re-listing and pushed both through as a single take-it-or-leave-it vote. The result is exceptional skin in the game living next to a deliberate concentration of control, and a US AML consent order that says compliance hasn't kept pace with growth.
The People Running This Company
The roster is unusual for a $13bn-plus listed financial. Käärmann still runs the company he co-founded fifteen years ago and remains its largest individual shareholder by a wide margin. The Chair is a former Netflix CFO with no Wise economic exposure beyond legacy options he is steadily monetising. The new CFO arrives from a payments-adjacent unicorn (Delivery Hero) and inherits an LTIP package that, by Wise's own admission, only exists because the company competes with US tech for finance talent. Operating leadership — Sinha (product/US), Peiris (product), Avila (banking/expansion) — is long-tenured and built from inside.
The notable absence is co-founder Taavet Hinrikus. He left the board in 2021, no longer holds an executive role, and is the public face of the dissent over the dual-class extension (more on that below). His vehicle Skaala Investments still controls roughly 11% of the votes. Treat him as an active outside shareholder, not a passive alumnus.
What They Get Paid
CEO pay vs median employee
— CEO : median Wiser Label
The CEO of a $13bn fintech earned $269,000 in FY2025 — less than a senior engineer at Wise and less than every Non-Executive Director except Rampell (who waives his fee). That is not a typo: Käärmann has elected to abstain from both the annual bonus and every LTIP cycle since the IPO. Pay-for-performance and dilution risk to outside shareholders from CEO equity grants are essentially zero.
The full LTIP machinery instead sits on the new CFO. Thomassin's normal FY2025 LTIP grant was 200% of salary in performance shares plus 200% in restricted shares ($2.6m at grant), and he received a one-time enhanced LTIP of equal size. FY2026 maximum opportunity is 400% of salary, gated on relative TSR vs FTSE 100, volume CAGR, underlying PBT margin, and customer NPS. That is a US-tech-style package on a UK-listed financial, justified explicitly by the talent market for global fintech CFOs. Shareholders have so far accepted it (the 2024 Remuneration Policy passed with 91.6% support).
The one item that grates is the leaving package for Matthew Briers, the prior CFO. He was treated as a "good leaver" on a 650%-of-salary PSP granted in October 2022, ultimately receiving 166,268 shares worth $2.21m at vesting in March 2025 — paid for a performance period he was not employed for the second half of. The Remuneration Committee considered downward discretion and declined to apply it.
Wise board total comp: $6.0m (incl. NEDs) on a $534m company-wide compensation pool spanning 6,151 Wisers. Leadership Team (10 non-board execs) collected $12.4m. The financial weight of the comp programme sits on the Leadership Team, not the Board.
Are They Aligned?
This is where the picture gets sharp. Founder economic interest is enormous; founder voting interest has been deliberately, and controversially, reinforced.
Ownership and control
The dual-class structure (Class A: 1 vote; Class B: 9 votes) was originally set to sunset in July 2026, five years after IPO. In the July 28, 2025 vote, shareholders bundled approval of the move to a US primary listing with a ten-year extension of Class B voting rights to 2035, taking total enhanced-voting tenure to 14 years post-IPO. The vote passed comfortably (Class A: 91% in favour; Class B: 84.5%) but only after a public objection from Hinrikus, who called the bundling "inappropriate and unfair" and inconsistent with Wise's own "radical transparency" principle. ISS and Glass Lewis initially missed that the proposal contained the dual-class extension at all; both later updated their reports while still recommending in favour. PIRC reversed its recommendation against.
The economic effect: the CEO's ~18% economic stake is converted into ~49% voting power (capped at one vote below 50% while CEO; capped at 35% if he steps down). For minority Class A holders, the practical right to change management has now been deferred from 2026 to 2035.
Insider buying / selling
There is no open-market insider buying in FY2025. The only outright open-market sale was by Chair David Wells, who liquidated 323,000 shares (combined sale and option exercise) at around $9.95 in July 2024. Wells holds no required shareholding (Chair does not have a 300% rule), so this is housekeeping rather than a vote of no confidence — but it is the only meaningful open-market activity. Käärmann has not bought, has not sold, and continues to hold 372m shares directly.
Skin in the game
Skin-in-the-game score
— /10 Suffix
Why 9/10: the CEO holds ~$4.5bn of Wise stock at recent prices, voluntarily takes only $269k in cash compensation, has never accepted an LTIP grant, and holds 26x his shareholding requirement. Capital allocation is shareholder-friendly (no dividends, no buybacks, profits reinvested in lower customer pricing — Mission Zero). The single point lost is for the deliberate use of the dual-class structure to lock in disproportionate control through 2035.
Capital allocation behaviour
No dividend, no buybacks under the standing 102.5m-share authority (which the directors state they have no present intention of using). Cash conversion is high (UFCF/PBT 118% in FY25); the explicit policy is to reinvest excess profits into lower customer prices and product. Dilution from share-based comp is bounded by Investment Association guidelines (10%/5% in 10 years) and the company states it is in compliance. For a fintech of this size, this is unusually clean.
Related parties
The disclosed related-party items are minor. The two structural conflicts that matter:
- Ingo Uytdehaage is Co-CEO of Adyen, which is a Wise supplier. He recuses on commercial negotiations.
- Alastair Rampell is a General Partner at Andreessen Horowitz, the largest VC-era backer (~38m Class A shares held via a16z funds). He waives all NED fees, which removes the cash incentive but not the potential conflict of interest in capital-markets decisions affecting the value of a16z's holding.
No self-dealing transactions are flagged in the directors' report or Note 26.
Board Quality
Independence is 62.5% of NEDs (excluding Chair) — meets UK CGC provision 11. Two non-independent NEDs (Käärmann's executive seat aside): Rampell is conflicted by virtue of a16z's stake, and the Nomination Committee itself is only 50% independent because it includes the Chair, the CEO, the SID, and one independent NED — Wise discloses this as a non-compliance with provision 17 and explains it on a comply-or-explain basis.
The board's strongest assets: Wells, a sitting Netflix-veteran chair with audit-chair credentials; Uytdehaage, who runs the only large-scale comparable payments platform; Tan, a founder-operator from Grab; Gilmartin, a tech CEO who has IPO'd and sold; Duhon, a sitting risk chair at Morgan Stanley International. The audit chair (Uytdehaage) running a Wise supplier creates a structural recusal pattern but his payments expertise is, in practice, irreplaceable on this board.
The visible weak spot is regulatory and risk depth at exactly the moment the company is becoming a global money-services business under multi-jurisdiction supervision. Five of nine directors have regulatory experience and five have risk experience by the board's own self-assessment, which sounds adequate until you set it against the AML compliance failures that surfaced in FY2025 (see below).
Compliance lapses that actually matter (FY2025). Two regulatory items hit during the year, both downstream of the US business:
- Multi-state AML consent order (Jul 2025): Wise US agreed to pay $4.2m ($700k each to MA, CA, MN, NE, NY, TX), file quarterly compliance reports for two years, and retain an independent monitor. Cited deficiencies: independent AML programme review and suspicious-activity investigation processes.
- CFPB consent order (FY2025): A $2m fine was later reduced to $45,000 after the Consent order findings were amended.
Neither is large in dollar terms, but the multi-state agreement is the kind of consent order that follows a company through future licence renewals.
The Verdict
Governance Grade
The case for an A: Founder-operator with $4.5bn at risk, no bonus, no LTIP, a 49.3% voting bloc that has been used to keep the company on its long-term Mission Zero pricing strategy rather than to extract perks. Independent chair from a credible US tech operator. No dividends, no buybacks, no related-party self-dealing, low pay ratio, and a genuinely diverse board with relevant operating experience. Capital allocation behaviour is exemplary.
Why it stops at B:
- The bundled dual-class extension. Wrapping the US listing decision and a 10-year extension of super-voting rights into a single 75%-supermajority vote — and the proxy advisers initially missing the bundle — is a deliberate concentration of control at the moment the company should be loosening it. The structure now runs to 2035.
- AML compliance gaps in the US business. A $4.2m multi-state consent order with an independent monitor and two years of quarterly reporting is a credible signal that the second line of defence has not scaled with the volume.
- The Briers good-leaver outcome. A $2.21m PSP vesting for a departed CFO who was not employed for the back half of the performance period, with the Committee declining to apply downward discretion, is a small data point but the wrong direction.
What would push this to A: a clean two years on the US AML monitor; an independent (or at minimum SID-led) decision on what happens to the dual-class structure ahead of 2035; and a future severance event handled with visible discretion. The single thing most likely to push it to C is a second material regulatory consent order, particularly one that names individuals or that the FCA brings in the home jurisdiction.
What the Internet Knows About Wise
Figures converted from GBP at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
The Bottom Line from the Web
The web tells two stories the filings don't. First, on 28 July 2025 shareholders approved relocating the primary listing from London to Nasdaq — but the proposal bundled a 10-year extension of the dual-class voting structure to 2036, a governance trade that ISS and Glass Lewis initially missed and that co-founder Taavet Hinrikus publicly opposed. Second, regulatory pressure on the company — and on CEO Kristo Käärmann personally — has compounded: the FCA fined him $469K (£350,000) in October 2024 over tax-disclosure failures, the CFPB ordered redress for misleading remittance practices in January 2025, and a six-state AML settlement followed in July 2025. The operating story (Q4 FY26 underlying income +24%, volumes +26%) is genuinely strong, but the governance and regulatory overhang materially changes the lens through which the print should be read.
What Matters Most
Last Price ($)
Consensus Target ($)
EV / EBITDA
Q4 FY26 Income ($M)
1. Primary listing moves to Nasdaq — with a dual-class extension bolted on
On 28 July 2025, 91% of Class A and 85% of Class B shareholders approved relocating the primary listing to the U.S. with a UK secondary. The proposal bundled a 10-year extension of the dual-class structure to 2036 that proxy advisers initially overlooked. Source: Reuters; governance scrutiny via Bloomberg.
2. Co-founder Taavet Hinrikus publicly opposed the listing
3. CEO Kristo Käärmann fined $469K by FCA for tax-disclosure failures
On 28 October 2024, the FCA fined Käärmann $469K (£350,000) to settle an investigation into his failure to notify the regulator about "significant tax issues" — having previously been fined by HMRC for "deliberately defaulting" on his taxes. The FCA found him "fit to continue" as CEO. Source: Reuters.
4. CFPB ordered redress for misleading remittance practices
On 30 January 2025, the CFPB ordered Wise US to pay $450,000 in redress + $2.025M civil penalty for misrepresenting ATM fees and failing to refund remittance fees. A modified consent order on 15 May 2025 reduced the civil penalty to $44,955 with the $450K redress retained. Source: CFPB.
5. $4.2M multi-state AML settlement; independent monitor required
In July 2025, six U.S. state regulators (CA, MA, MN, NE, NY, TX) settled with Wise US over BSA/AML deficiencies discovered during a July 2022 – Sep 2023 examination. Wise must retain an independent monitor and report quarterly for two years. Source: PaymentsDive.
6. Strong operating momentum: Q4 FY26 income +24%, volumes +26%
Q4 FY26 underlying income $576.4M ($435.3M GBP), cross-border volume $65.4B (+26% YoY), 11.3M active customers. Shares jumped 5%+ on the print. Source: MarketScreener, Bloomberg.
7. Investment-grade BBB / Stable from S&P and Fitch
8. CEO voting power contractually capped just below 50%
A recent share-capital update disclosed Käärmann's stake would translate to more than 50% of voting rights without a contractual cap; he is bound to keep voting power just below 50% while remaining CEO. Source: TipRanks.
9. Application to OCC for U.S. national trust bank
On 2 July 2025, Wise applied to be directly regulated by the U.S. Office of the Comptroller of the Currency as a national trust bank — a major step for U.S. infrastructure independence post-listing. Source: Reuters.
10. Q3 FY26 print (6 Nov 2025): shares fell 6.6% on slowing revenue growth
Despite meeting financial targets, slowing top-line growth caused a 6.6% share decline on 6 November 2025. The narrative around take-rate compression and margin trade-offs intensified. Source: Investing.com.
11. Stablecoin pivot signal — hire of digital-asset product lead
In October 2025, Wise hired a digital-asset product lead at a $192K salary — institutional acknowledgement that stablecoin infrastructure is a real disruption threat to Wise's correspondent-banking-bypass moat. Source: AInvest.
12. Take-rate compression is structural — by design
Wise operates a "Scale Economies Shared" model: it explicitly cuts take rate as it scales (most recently in April 2024), passing efficiency to customers. Take rate is ~60bps versus 10x for traditional banks; management has guided that "cross-currency take rate will go down year by year." Source: Capital Compounding.
13. JPMorgan raised target to $16.69 (17 April 2026)
JPM lifted its 12-month target to $16.69 from $16.22. Consensus average target ~$16.25 (range $10.17 – $20.86 across 18 analysts). Source: CNBC.
14. Relative-PE intrinsic-value model implies meaningful downside
A ValueInvesting.io relative-PE fair-price model gives $7.06 vs. $13.92 price = -49.3% downside; PEG 6.54; EV/EBITDA 22.08 (rising from ~17 in late Feb 2026). Cited as a single model — not consensus. Source: ValueInvesting.io.
15. No dividend, no buyback; capital reinvested
Wise pays no dividend and has no buyback program disclosed. Capital is reinvested in payment-rail integrations, regulatory licences and the Wise Platform. Source: DividendMax.
Recent News Timeline
What the Specialists Asked
Insider Spotlight
Kristo Käärmann (CEO, co-founder)
Holds ~16% directly per Simply Wall St (other sources cite ~18.8% at IPO). Annual total compensation $275K (£208,100) — extraordinarily low for an $18B-class market-cap CEO; aligned with founder economics. FCA fined him $469K (£350,000) on 28 October 2024 for "careless" failure to notify the regulator of significant tax issues; HMRC had previously penalised him for "deliberately defaulting" on his taxes. FCA found him fit to remain. Voting power contractually capped just below 50% while CEO. Took 4-month paternity leave from Sep 2023.
Taavet Hinrikus (co-founder)
Held ~10.9% ($1.52B) at 2021 listing; sold up to 11M Class A shares at $10.97 (4% discount) on 22 Oct 2021. Stepped down as Chair in Dec 2021. Co-founded Plural Platform (€250M VC fund, Jun 2022). On 21 July 2025 publicly opposed the U.S. listing over the bundled dual-class extension — the most material public dissent of his post-Wise tenure.
Other directors and recent dealings
David Wells (Chair, ex-Netflix CFO, Dec 2021–); Emmanuel Thomassin (CFO, 2024); Ingo Uytdehaage (Adyen co-CEO, board since 2021); Harsh Sinha (Wise US president & CTO since 2015); SerJin Lee (Chief Compliance Officer, 2024 — relevant given AML actions); Cian Weeresinghe (CMO, 2021); Isabel Naidoo (CPO, 2022). Most recent insider event: long-term incentive grant of 90,396 Class A restricted shares to the Global Banking Chief (~Apr 2026).
Industry Context
Pricing dynamics. Wise charges ~60bps blended versus ~10x for traditional banks, and explicitly cuts price as it scales (most recent cut April 2024) under a "cost-plus" pricing model. Card revenue grew 54% YoY. The structural take-rate compression is by design — and is the central reason Q3 FY26 (Nov 2025) caused a 6.6% share decline despite volume strength.
Regulatory environment. UK FCA (Wise is an authorised EMI; CEO action), U.S. CFPB consent order (Jan 2025), six-state AML coordinated action (Jul 2025), pending OCC application for national trust bank charter (Jul 2025). EU MiCA effective 2026; U.S. GENIUS Act (Feb 2025) sets the stablecoin framework.
Stablecoin disruption threat. Stablecoin market cap $300B+; Visa, Mastercard and Circle integrating stablecoins. Wise hired a digital-asset product lead ($192K salary, Oct 2025) and is "prioritising infrastructure over immediate product launches" — institutional acknowledgement that the threat is real to its bypass moat.
London exchange context. Wise's defection to Nasdaq is part of a broader exodus (Diversified Energy also moved). The FCA CEO publicly disputed that listing rules were responsible for departures — a reminder that the listing-venue debate is regulatory-political, not purely commercial.
All figures converted from GBP at historical FX rates (period-end where available, see <code>data/company.json.fx_rates</code>). Ratios, multiples and percentages are unitless and unchanged.
Liquidity & Technicals
Figures converted from GBP at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, multiples, percentages, and unitless technical indicators (RSI, MACD, realized volatility) are unchanged.
The verdict in two sentences. Wise trades $21.2M of stock per day against a $17.6B market cap — a turnover ratio of 0.12% that puts the name in capacity-constrained specialist territory; a 0.5% issuer-level position needs three weeks to build or exit at 20% participation. Technically, price has clawed back above the 200-day SMA after a November death-cross sell-off, but the 50-day still trades below the 200-day and the rally has run on shrinking volume — constructive but unconfirmed.
Portfolio implementation verdict
5-day capacity @ 20% ADV ($M)
Max 5-day position (% mcap)
Fund AUM @ 5% weight ($M)
ADV / mcap (%)
Tech stance score
Capacity-constrained, specialist sizing only. Daily turnover is 0.12% of market cap; even patient execution at 20% of ADV builds only $21M in five sessions. Position weights of 5% are realistic for funds up to roughly $425M; a 1% issuer-level stake takes six weeks to exit. Liquidity, not the chart, is the binding constraint.
Price snapshot
Last price ($)
YTD return (%)
1-year return (%)
52-week position (percentile)
1-month return (%)
Beta is omitted: no UK broad-market benchmark series was loaded for this run, and a single-asset history without a paired index cannot anchor a defensible beta.
Trend — full price history with 50/200-day SMA
Most recent moving-average cross: death cross on 10 November 2025 (50-day fell below 200-day). Price has since rallied roughly 30% off the $10.65 trough, but the 50-day SMA ($12.48) remains below the 200-day SMA ($12.73) — the bearish configuration has not yet flipped.
Price is above the 200-day SMA by 8.7%. The post-IPO history splits into three clean regimes: a year-long de-rating from the $12.19 direct-listing reference to the $3.25 all-time low in October 2022; a recovery through 2023–2024 that printed two golden crosses (July 2023, December 2024); and a renewed downtrend through mid-2025 that produced the November 2025 death cross. The current setup is a textbook recovery-from-death-cross — price has reclaimed the 200-day but the moving-average configuration has not confirmed.
Relative strength vs benchmark + sector
No benchmark series was successfully loaded for this run (UK broad-market ETF EWU was the intended reference). Sector ETF and peer basket are also unavailable. Relative-strength analysis is deferred — the company-only series is shown above; pair-against-index comparisons should be sourced from the Quant or Variant pages.
Momentum — RSI(14) and MACD histogram, last 18 months
RSI sits at 60.8 — bullish but not overbought; the indicator has held above 50 for most of the last six weeks, consistent with the rally. MACD is the more cautious read: the line is positive but already crossed below its signal line, and the histogram has flipped negative — momentum is decelerating even as price grinds higher. The combination is a near-term bullish-but-fading setup, the kind that often gives back recent gains before resolving in either direction.
Volume, volatility, and sponsorship
The most striking feature: the recent 16% one-month rally has run on below-average volume. The 5-day average sits near 1.0M shares against a 50-day average of 1.74M — sponsorship is not confirming the move. Combined with the MACD divergence, this is the single weakest element of the technical picture.
Top volume events (5-year window)
The 31 May 2023 print — 22.6× average volume on an 8.3% rally — coincides with Wise's FY23 full-year results and stands out as the cleanest positive earnings reaction in the post-IPO record. The other top spikes are mostly downside reactions to mid-period updates.
Realized volatility (30-day rolling, 5-year history)
Realized vol is currently 29.5% — between the 5-year p20 (25.2%) and p50 (34.7%) bands, which the methodology classifies as normal-to-calm. That matters: the recent rally is not the kind of vol-crush mean reversion that follows a panic. It is being absorbed in an orderly tape, which makes patient accumulation defensible — but also means there is no compressed-vol catalyst force-feeding upside.
Institutional liquidity panel
This name is flagged illiquid in the run manifest. Average daily turnover of $21M against a $17.6B market cap means even moderate institutional positions face multi-week execution windows. The numbers below are computed from clean, observed trading (100% volume coverage, zero zero-volume days over 60 sessions) — the constraint is real, not a data artefact.
ADV and turnover
ADV 20d (M shares)
ADV 20d ($M)
ADV 60d (M shares)
ADV / mcap (%)
Annual turnover (% float)
Fund-capacity table
Reverse the math: at a normal 20% participation rate, a fund running this name as a 5% position needs to be $425M or smaller to clear the 5-day execution test; a 2% position works up to $1.07B. At a more conservative 10% participation, those numbers halve. For most multi-billion equity funds, Wise is either a bench-position or an out-of-bench specialist sleeve — not a flagship holding.
Liquidation runway
A 0.5%-of-mcap position ($88M) takes three trading weeks to exit at full institutional aggression and over two months at a more cautious 10% rate. A 1% position is a six-to-seventeen-week project. No issuer-level position size of 0.5% or larger clears the 5-day threshold — the data field reads 0.0%.
Execution friction
The 60-day median daily range is 1.10% — under the 2% threshold above which intraday impact starts compounding. Bid-ask cost is not the problem here; the problem is sheer volume per day relative to mcap. There are no zero-volume days in the trailing 60-session window, and volume coverage is 100%. The friction is one of capacity, not of trading microstructure.
Technical scorecard and stance
Net score: +1. Stance: neutral with a bullish lean over the 3-to-6 month horizon. The recovery from the November 2025 death cross is real — price has reclaimed the 200-day SMA on a normal-vol tape — but the rally lacks the volume signature that usually accompanies a durable trend change, and the MACD has begun to fade. A break above $15.36 (the 52-week high) closes out the bearish moving-average configuration and validates the recovery; a loss of $12.71 (the 200-day SMA) marks the rally as a counter-trend bounce and reopens the path to the $10.65 52-week low. Liquidity is the constraint, not the tape: even with a constructive technical view, this is a slow-build name suitable for funds under $425M targeting a 5% weight, or larger funds willing to run it as a sub-2% specialist position over multiple weeks.